Arrow Fat Left Icon Arrow Fat Right Icon Arrow Right Icon Cart Icon Close Circle Icon Expand Arrows Icon Facebook Icon Instagram Icon Twitter Icon Youtube Icon Hamburger Icon Information Icon Down Arrow Icon Mail Icon Mini Cart Icon Person Icon Ruler Icon Search Icon Shirt Icon Triangle Icon Bag Icon Play Video

Diagnostics on demand.
Providing you with simple, easy access to world-leading laboratories that deliver the broadest range of wellness focussed diagnostic testing services.
For health professionals and patients across the UK and around the world.

Doctors Data - HOR18

Comprehensive Neurotransmitter Profile

Hormones Urine Turn Around Time: 12 Days
Recommended: Contact practitioner before placing order
Turn Around Time: 12 Days

Description

The Comprehensive Neurotransmitter Profile is a non-invasive urinary assessment of the body's ability to secrete and metabolise neurotransmitters. Neurotransmitters are secreted all through the body, in neurons of both the central and peripheral nervous systems. The enzymes, cofactors and precursors in neurotransmitter metabolism are similar in the periphery and in the central nervous system so alterations in urinary neurotransmitter levels provide clinically important information and valuable insights for a range of health concerns.

Methodology

Neurotransmitters and metabolites by LC-MS/MS
Creatinine by Enzymatic Colorimetric - Kinetic Jaffee

When should I use

Neurotransmitter analysis provides an overall assessment of a patient's ability to synthesize and metabolize neurotransmitters, which must occur in both the peripheral nervous system and behind the blood brain barrier (BBB). Alterations in urinary neurotransmitter status may result from a variety of conditions including metabolic disorders, mood/behavioural disorders, environmental exposures or (rarely) the presence of certain tumours. Evaluation of neurotransmitters may provide increased clarity about a patient's health and functional status.

Information gained through neurotransmitter testing may provide therapeutic opportunities that improve clinical success and patient health outcomes. Associations between urinary neurotransmitter levels and health conditions have been documented in scientific literature and may provide valuable insight as part of a comprehensive health assessment.
Consider for the following:
Mood concerns, such as depression, anxiety
Diminished energy/fatigue
Insomnia
Cognitive concerns such as forgetfulness, inattention, brain fog
Addiction, dependency
Obsessions and cravings
Chronic illness, immune deficiency
Pain
Low libido, sexual dysfunction

Other Details

Can be an add-on for HuMap (use test code DD013AO)
  • 3
  • 3-Methoxytyramine (3-MT)
  • 5-Hydroxyindolacetate (5HIAA)
  • Acetate
  • Butyrate
  • Creatinine
  • Dopamine
  • Epinephrine
  • Gamma-aminobutyrate (GABA)
  • Glutamate
  • Glycine
  • Histamine
  • Metanephrine
  • Norepinephrine
  • Norepinephrine / Epinephrine ratio
  • Normetanephrine
  • Phenethylamine (PEA)
  • Serotonin
  • Taurine
  • Tryptamine
  • Tyramine
  • Tyrosine

View Details

Description

The Comprehensive Neurotransmitter Profile is a non-invasive urinary assessment of the body's ability to secrete and metabolise neurotransmitters. Neurotransmitters are secreted all through the body, in neurons of both the central and peripheral nervous systems. The enzymes, cofactors and precursors in neurotransmitter metabolism are similar in the periphery and in the central nervous system so alterations in urinary neurotransmitter levels provide clinically important information and valuable insights for a range of health concerns.

Methodology

Neurotransmitters and metabolites by LC-MS/MS
Creatinine by Enzymatic Colorimetric - Kinetic Jaffee

When should I use

Neurotransmitter analysis provides an overall assessment of a patient's ability to synthesize and metabolize neurotransmitters, which must occur in both the peripheral nervous system and behind the blood brain barrier (BBB). Alterations in urinary neurotransmitter status may result from a variety of conditions including metabolic disorders, mood/behavioural disorders, environmental exposures or (rarely) the presence of certain tumours. Evaluation of neurotransmitters may provide increased clarity about a patient's health and functional status.

Information gained through neurotransmitter testing may provide therapeutic opportunities that improve clinical success and patient health outcomes. Associations between urinary neurotransmitter levels and health conditions have been documented in scientific literature and may provide valuable insight as part of a comprehensive health assessment.
Consider for the following:
Mood concerns, such as depression, anxiety
Diminished energy/fatigue
Insomnia
Cognitive concerns such as forgetfulness, inattention, brain fog
Addiction, dependency
Obsessions and cravings
Chronic illness, immune deficiency
Pain
Low libido, sexual dysfunction

Other Details

Can be an add-on for HuMap (use test code DD013AO)

View Analytes

  • 3
  • 3-Methoxytyramine (3-MT)
  • 5-Hydroxyindolacetate (5HIAA)
  • Acetate
  • Butyrate
  • Creatinine
  • Dopamine
  • Epinephrine
  • Gamma-aminobutyrate (GABA)
  • Glutamate
  • Glycine
  • Histamine
  • Metanephrine
  • Norepinephrine
  • Norepinephrine / Epinephrine ratio
  • Normetanephrine
  • Phenethylamine (PEA)
  • Serotonin
  • Taurine
  • Tryptamine
  • Tyramine
  • Tyrosine
English